Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Health Policy (Amsterdam, Netherlands)|May 11, 2012
The role of proximity to death in need-based approaches to health careYukiko Asada, George Kephart, Jeremiah Hurley, et al.Healthcarepapers|May 22, 2008
Parallel payers and preferred access: how Canada's Workers' Compensation Boards expedite care for injured and ill workersJeremiah Hurley, Dianna Pasic, John N Lavis, et al.Healthcare Policy = Politiques De Sante|April 21, 2009
Parallel Lines Do Intersect: Interactions between the Workers' Compensation and Provincial Publicly Financed Healthcare Systems in CanadaJeremiah Hurley, Dianna Pasic, John N Lavis, et al.Healthcare Policy = Politiques De Sante|August 2, 2012
Population aging and the determinants of healthcare expenditures: the case of hospital, medical and pharmaceutical care in british columbia, 1996 to 2006Steven Morgan, Colleen CunninghamCMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 17, 2016
A population-based analysis of incentive payments to primary care physicians for the care of patients with complex diseaseM Ruth Lavergne, Michael R Law, Sandra Peterson, et al.Health Policy (Amsterdam, Netherlands)|November 21, 2017
Effect of incentive payments on chronic disease management and health services use in British Columbia, Canada: Interrupted time series analysisM Ruth Lavergne, Michael R Law, Sandra Peterson, et al.International Journal of Health Geographics|October 17, 2003
Geographic disparity in premature mortality in Ontario, 1992-1996Chris A Altmayer, Brian G Hutchison, Vicki L Torrance-Rynard, et al.Health Affairs (Project Hope)|May 27, 2004
Outcomes-based drug coverage in British ColumbiaSteven Morgan, Ken Bassett, Barbara MintzesHealth Affairs (Project Hope)|April 10, 2013
International best practices for negotiating 'reimbursement contracts' with price rebates from pharmaceutical companiesSteven Morgan, Jamie Daw, Paige ThomsonOpen Medicine : a Peer-Reviewed, Independent, Open-Access Journal|May 24, 2011
Toward a definition of pharmaceutical innovationSteven Morgan, Ruth Lopert, Devon GreysonPageof 8